The GLP receptor is present on many different cell types in the body, from the digestive system to the brain to the immune system, Dr
If a patient does not respond to the first-line therapy (amitriptyline, cyproheptadine, and/or propranolol) the following options should be considered: (1) presence of persisting triggers (e.g., psychological stressors) and comorbid conditions (e.g., anxiety, POTS) or missed underlying disorders (e.g., hydronephrosis, chronic sinusitis, acute appendicitis, intestinal malrotation with volvulus, CNS tumors, metabolic crises) and toxic exposure (e.g., cannabis)
doi: 10.1111/dom.12932 [DOI] [PMC free article] [PubMed] [Google Scholar] 241
[DOI] [PubMed] [Google Scholar] 8.World Health Organisation (WHO)-Uppsala Monitoring Centre (UMC): The use of the WHO-UMC system for standardised case causality assessment
Experimental Pathology, 38 (3), 145164